Estimation of the Cost of Smoking-Attributable Diseases (Five Selected Diseases): A Case in Kerman City, Iran, 2014

Document Type : Original Article(s)

Authors

1 Department of Policy Management and Health Economics, School of Health Management and Medical Informatics, Kerman University of Medical Sciences, Kerman, Iran

2 General Practitioner, Management of Medical Treatment and Medical Documents of the Social Security Organization, Kerman, Iran

3 Professor, Neuroscience Research Center, Institute of Neuropharmacology, Kerman University of Medical Sciences, Kerman, Iran

4 Health Insurance Organization, Kerman, Iran

5 Associate Professor, Health Services Management Research Center, Institute for Futures Studies in Health, Kerman University of Medical Sciences, Kerman, Iran

Abstract

Background: Cigarette seems to be the least valuable of addictive drugs. It is easily accessible to the public, and its harmful personal and social effects have attracted less attention. Therefore, the present research was carried out with the aim of presenting cost estimations of smoking-related diseases in smokers who aged 35 or higher in Kerman City, Iran, in 2014.Methods: Using the prevalence approach, the direct and indirect costs of smoking-attributable diseases including lung cancer, gastric cancer, myocardial infarction, stroke, and chronic obstructive pulmonary disease (COPD) were estimated. The initial data were obtained from the information in documents of medical document units as well as the 2014 income statements of teaching hospitals of Kerman University of Medical Sciences, Kerman City.Findings: In this research, total economic costs of diseases attributed to smoking were estimated to be 50 million dollars in 2014 in Kerman City, and calculations suggest that this figure accounts for 0.02% of Iran’s gross domestic product (GDP). Total direct cost of diseases caused by smoking in Kerman City adds up to 17 million dollars, whereas the estimated indirect cost of diseases caused by smoking is 33 million dollars. The yearly per capita cost of any of the selected five diseases is 270 dollars.Conclusion: Smoking places a high economic burden on health system and society as a whole. Therefore, stronger intervention measures against smoking should be taken without delay to reduce the health and financial losses caused by smoking.

Keywords

References

  1. Amini AR, Hejazi Azad Z. An analysis and assessment of health contribution to increasing labor productivity. Iranian Journal of Economic Research 2007; 9(30): 137-64. [In Persian].
  2. Mehrbani V. Labor health and economic growth in Iran. Social Welfare Quarterly 2010; 10(37): 327-50. [In Persian].
  3. Barro RJ. Determinants of economic growth: A cross-country empirical study. Cambridge, MA: The MIT Press; 1998.
  4. Danesh-Jafari D. We will increase the 5% portion of health from the GDP [Online]. [cited 2014]; Available from: URL:
  5. http://www.behdasht.gov.ir/?siteid=1&pageid=1508&newsview=110888. [In Persian].
  6. Karimi S, Javadi M, Jafarzadeh F. Economic burden and costs of chronic diseases in Iran and the world. Health Inf Manage 2011; 8(7): 984. [In Persian].
  7. Ayatollahi J. Smoking and tuberculosis. J Shaheed Sadoughi Univ Med Sci 2005; 13(1): 75-84. [In Persian].
  8. Tabibzadeh Nouri Z, Atapour S, Ebn Ahmady A. The effects of simulated patient training on senior dental students' confidence and skills in delivering a tobacco cessation counseling program in school of dentistry, Sshahid Beheshti University of Medical Sciences, 2010-2011. J Dent Sch Shahid Beheshti Univ Med Sci 2012; 29(4): 290-8. [In Persian].
  9. Tobacco Free Initiative (TFI): WHO report on the global tobacco epidemic 2013: Enforcing bans on tobacco advertising, promotion and sponsorship [Online]. [cited 2013]; Available from: URL: http://www.who.int/tobacco/global_report/2013/en
  10. World Health Organization, Economics of Tobacco Toolkit. Assessment of the economic costs of smoking. Geneva, Switzerland: WHO; 2011.
  11. Yang L, Sung HY, Mao Z, Hu TW, Rao K. Economic costs attributable to smoking in China: Update and an 8-year comparison, 2000-2008. Tob Control 2011; 20(4): 266-72.
  12. Scarborough P, Bhatnagar P, Wickramasinghe KK, Allender S, Foster C, Rayner M. The economic burden of ill health due to diet, physical inactivity, smoking, alcohol and obesity in the UK: An update to 2006-07 NHS costs. J Public Health (Oxf) 2011; 33(4): 527-35.
  13. Oster G, Colditz GA, Kelly NL. The economic costs of smoking and benefits of quitting for individual smokers. Prev Med 1984; 13(4): 377-89.
  14. Szklo M, Javier Nieto F. Epidemiology: Beyond the basics. Burlington, MA: Jones & Bartlett Publishers; 2014.
  15. Lim SS, Vos T, Flaxman AD, Danaei G, Shibuya K, Adair-Rohani H, et al. A comparative risk assessment of burden of disease and injury attributable to 67 risk factors and risk factor clusters in 21 regions, 1990-2010: A systematic analysis for the Global Burden of Disease Study 2010. Lancet 2012; 380(9859): 2224-60.
  16. World Health Organization. Tobacco Free Initiative (TFI): WHO report on the global tobacco epidemic 2015 [Online]. [cited 2015]; Available from: URL: http://www.who.int/tobacco/global_report/2015/en
  17. Karimloo M, Nourbala AA, Madjdzadeh R, Karimlou M. Trend of smoking prevalence in Iran from 1991 to 1999 based on two national health survey. Hakim Res J 2001; 3(4): 290-4. [In Persian].
  18. Nakhaee N, Divsalar K, Bahreinifar S. Prevalence of and factors associated with cigarette smoking among university students: A study from Iran. Asia Pac J Public Health 2011; 23(2): 151-6.
  19. Halimi L, Haghdoost AA, Mohammad Alizadeh S. Prevalence of cigarette smoking among Iranian women: A systematic review and meta-analysis. Med J Islam Repub Iran 2013; 27(3): 132-40.
  20. Kang HY, Kim HJ, Park TK, Jee SH, Nam CM, Park HW. Economic burden of smoking in Korea. Tob Control 2003; 12(1): 37-44.
  21. World Health Organization. Impact of tobacco-related illness in Bangladesh. New Delhi, India: WHO; 2007.
  22. Ross H, Trung DV, Phu VX. The costs of smoking in Vietnam: The case of inpatient care. Tob Control 2007; 16(6): 405-9.
  23. John RM, Sung HY, Max W. Economic cost of tobacco use in India, 2004. Tob Control 2009; 18(2): 138-43.
  24. Finegold JA, Asaria P, Francis DP. Mortality from ischaemic heart disease by country, region, and age: Statistics from World Health Organisation and United Nations. Int J Cardiol 2013; 168(2): 934-45.
  25. Khosravi A, Aghamohamadi S, Kazemi E, Pourmalek F, Shariati M. Mortality Profile in Iran (29 Provinces) over the Years 2006 to 2010. Tehran, Iran: Ministry of Health and Medical Education; 2012. [In Persian].
  26. Samavat T, Hojatzadeh A, Shams M, Afkhami A, Mahdavi AR, Bashti S. Prevention and control programs Cardiovascular. Tehran, Iran: Ministry of Health and Medical Education; 2012. [In Persian].
  27. National Center for Chronic Disease Prevention and Health Promotion (US) Office on Smoking and Health. The Health Consequences of Smoking-50 Years of Progress: A Report of the Surgeon General. Atlanta, GA: Centers for Disease Control and Prevention; 2014.
  28. Johnston SC, Mendis S, Mathers CD. Global variation in stroke burden and mortality: Estimates from monitoring, surveillance, and modelling. Lancet Neurol 2009; 8(4): 345-54.
  29. Oberg M, Jaakkola MS, Woodward A, Peruga A, Pruss-Ustun A. Worldwide burden of disease from exposure to second-hand smoke: A retrospective analysis of data from 192 countries. Lancet 2011; 377(9760): 139-46.
Addiction & Health
Volume 9, Issue 4 - Serial Number 4
25
November 2017
Pages 190-198

Files

Share

How to cite

Statistics